Year archive

M&A deals in 2026

Browse every published Exit Mode deal announced in 2026, sorted newest first with sectors, valuations, and Founder's Lens commentary where relevant.

The 2026 archive shows how buyer appetite, sector concentration, and deal tempo developed across the year. Use it to compare like-for-like transactions and track where activity accelerated or slowed.

1 June 2026CompletedHealthcare

Servier Pharmaceuticals LLC and Les Laboratoires Servier to acquire Edgewise Therapeutics, Inc.

Servier Pharmaceuticals LLC and Les Laboratoires Servier have agreed to acquire Edgewise Therapeutics, Inc. in a strategic acquisition valued at $2.65 billion. The trans…

Buyer
Servier Pharmaceuticals LLC and Les Laboratoires Servier
Target
Edgewise Therapeutics, Inc.
Deal value
USD 2,650,000,000
Deal type
strategic acquisition

More M&A Tools

Explore the Toolkit

Tools, frameworks and AI assistants designed for entrepreneurs serious about M&A.

Access now

Keep browsing

Explore the archive from another angle

All deals